SOFINNOVA CAPITAL VI FCPR 4
4 · HOOKIPA Pharma Inc. · Filed Mar 24, 2021
Insider Transaction Report
Form 4
SOFINNOVA CAPITAL VI FCPR
10% Owner
Transactions
- Sale
Common Stock
2021-03-22$14.54/sh−40,534$589,263→ 3,699,430 total
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 trading plan dated September 30, 2020 previously adopted by the Reporting Person.
- [F2]Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.